eye disorder – media

One Stop Solution for Dry Eye Syndrome

Recently in an annual meeting of ARVO (Association for Research in Vision and Ophthalmology) which had taken place in Hawaii, Sylentis – the pharma company belonging to PharmaMar Group and a pioneer in RNAi research, had presented the positive results from the clinical studies on tivanisiran therapy against dry eye syndrome.
- Source: Ddu
- 618
- May 22, 2018
eye disorder Researches
MeiraGTx Earns EMA PRIME Designation for Achromatopsia Gene Therapy Candidate

A new gene therapy to treat a debilitating eye disorder is one step closer to regulatory approval in Europe. Gene therapy company MeiraGTx said the European Medicines Agency granted Priority Medicines (PRIME) designation to its candidate A002 for treatment of achromatopsia.
- Source: biospace
- 415
- March 5, 2018
achromatopsia eye disorder New Approvals

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.